Response to Federal Government’s National Innovation and Science Agenda | Deloitte Australia | Life Sciences & Health Care has been added to your bookmarks.
Response to Federal Government’s National Innovation and Science Agenda
7 December 2015: The Federal Government today announced details of its new National Innovation and Science Agenda, outlining its plans to foster and incentivise innovation in Australia.
Helen Fisher, Lead Tax Partner for Life Sciences and Health Care, Deloitte commented:
“The Government should be congratulated for what it has achieved over the past three months in this area. The National Innovation and Science Agenda released today is a welcome first step to encouraging greater innovation, including commercialisation, in Australia.
“The investor incentive, which is based on the UK’s successful Seed Enterprise Investment Scheme for small start-ups, is less generous, but has the potential to create an immediate flow of capital to the industries that drive innovation. It will help kick start this vital part of the Australian economy, although most measures will only be introduced from 2017.
“Separately, although not part of the Agenda, we also understand an Australian patent box is still being considered and the Board of Taxation is currently reviewing proposals around this particular incentive. The Australian Innovation and Manufacturing (AIM) Incentive, developed by industry bodies, such as AusBiotech, Medical Technologies Association of Australia, Export Council of Australia, and Cook Medical, has been put forward as a model, and we understand it is compliant with the OECD’s recently released BEPS reports.
“There are also a number of other measures currently stimulating innovation culture across a variety of government portfolios and included in the Agenda, including a stronger focus on STEM education, immigration rules and relaxation of bankruptcy rules without promoting undue recklessness.
“The Agenda seeks to provide a rounded approach that includes most players in the innovation ecosystem, including universities, start-ups, investors, and skills and talent. Having a complete suite of measures will provide a strong platform from which Australian companies can compete in the global market.”
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/au/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms.
Deloitte provides audit, tax, consulting, and financial advisory services to public and private clients spanning multiple industries. With a globally connected network of member firms in more than 150 countries, Deloitte brings world-class capabilities and high-quality service to clients, delivering the insights they need to address their most complex business challenges. Deloitte has in the region of 200,000 professionals, all committed to becoming the standard of excellence.
About Deloitte Australia
In Australia, the member firm is the Australian partnership of Deloitte Touche Tohmatsu. As one of Australia’s leading professional services firms, and winner of both the Australian Financial Review/CFO Audit Firm of the Year and Accounting Firm of the Year awards 2013, Deloitte Touche Tohmatsu and its affiliates provide audit, tax, consulting, and financial advisory services through approximately 6,000 people across the country. Focused on the creation of value and growth, and known as an employer of choice for innovative human resources programs, we are dedicated to helping our clients and our people excel. Formore information, please visit Deloitte’s web site at www.deloitte.com.au.
Liability limited by a scheme approved under Professional Standards Legislation.
Member of Deloitte Touche Tohmatsu Limited
© 2015 Deloitte Touche Tohmatsu